Abstract
Pulmonary changes in thrombin formation in patients with acute lung injury or pneumonia are remarkably similar to systemic changes in coagulation observed in septic patients. Since anticoagulant therapy has proven to be successful in the treatment of patients with sepsis, the same therapeutic strategy may benefit patients with acute lung injury or pneumonia. Based on the fact that inflammation not only leads to dysregulation of the coagulation system, but vice versa, activation of coagulation amplifies inflammatory processes as well, it can be questioned whether the advantage of anticoagulant therapy is solely related to its influence on disturbed thrombin formation. In this paper we will discuss local changes in the haemostatic balance during acute lung injury, both in pre-clinical and clinical studies. Until now, pre-clinical studies have demonstrated that interventions aimed at correction of coagulation abnormalities may form an important strategy in patients with acute lung injury in the future. Pre-clinical studies on use of anticoagulants during pneumonia are presently performed and data are underway.
Keywords: coagulation, fibrinolysis, sepsis, acute lung injury, pneumonia, bronchoalveolar fluid, cytokines, thrombin, tissue factor
Current Drug Targets
Title: Anticoagulant Therapy for Acute Lung Injury or Pneumonia
Volume: 4 Issue: 4
Author(s): Marcus J. Schultz, Marcel Levi and Tom van der Poll
Affiliation:
Keywords: coagulation, fibrinolysis, sepsis, acute lung injury, pneumonia, bronchoalveolar fluid, cytokines, thrombin, tissue factor
Abstract: Pulmonary changes in thrombin formation in patients with acute lung injury or pneumonia are remarkably similar to systemic changes in coagulation observed in septic patients. Since anticoagulant therapy has proven to be successful in the treatment of patients with sepsis, the same therapeutic strategy may benefit patients with acute lung injury or pneumonia. Based on the fact that inflammation not only leads to dysregulation of the coagulation system, but vice versa, activation of coagulation amplifies inflammatory processes as well, it can be questioned whether the advantage of anticoagulant therapy is solely related to its influence on disturbed thrombin formation. In this paper we will discuss local changes in the haemostatic balance during acute lung injury, both in pre-clinical and clinical studies. Until now, pre-clinical studies have demonstrated that interventions aimed at correction of coagulation abnormalities may form an important strategy in patients with acute lung injury in the future. Pre-clinical studies on use of anticoagulants during pneumonia are presently performed and data are underway.
Export Options
About this article
Cite this article as:
Schultz J. Marcus, Levi Marcel and Poll van der Tom, Anticoagulant Therapy for Acute Lung Injury or Pneumonia, Current Drug Targets 2003; 4 (4) . https://dx.doi.org/10.2174/1389450033491064
DOI https://dx.doi.org/10.2174/1389450033491064 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Imiquimod 5% Cream Use in Dermatology, Side Effects and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors
Current Pharmaceutical Biotechnology Editorial [Hot topic: Endocannabinoid Signaling and Neuroinflammatory Diseases (Executive Editor: Mauro Maccarrone)]
Current Pharmaceutical Design Advances in Allergen-Specific Immunotherapy
Current Drug Targets Immunomodulatory Effects of Endogenous and Synthetic Peptides Activating Opioid Receptors
Mini-Reviews in Medicinal Chemistry Novel Dibenzothiepins with Antibiofilm Activity Demonstrated by Microbiological Assays and Molecular Modeling
Current Organic Chemistry Stability-indicating TLC /Densitometric Method for Simultaneous Analysis of Febuxostat and Diclofenac Potassium in Bulk and Tablets
Current Pharmaceutical Analysis Migration of Local Progenitor Cells as Therapeutic Target in Knee Osteoarthritis
Current Rheumatology Reviews Role of Wnt Signaling in Tissue Fibrosis, Lessons from Skeletal Muscle and Kidney
Current Molecular Medicine Insulin Resistance, Obesity and the Metabolic Syndrome. Is there a Therapeutic Role for Endothelin-1 Antagonists?
Current Vascular Pharmacology Hydroxytyrosol Attenuates LPS-Induced Acute Lung Injury in Mice by Regulating Autophagy and Sirtuin Expression
Current Molecular Medicine Chronic Paroxetine Treatment: Effects on Other Non-Serotonergic Neurotransmitter Systems
CNS & Neurological Disorders - Drug Targets Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity
Current Molecular Medicine <i>Trigonella foenum-graecum</i> Seeds Oil Attenuated Inflammation and Angiogenesis in vivo through Down-Regulation of TNF-α
Anti-Cancer Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Drug Repurposing for the Treatment of Staphylococcal Infections
Current Pharmaceutical Design Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Current Neuropharmacology Hemoglobin Enhances the Biological Activity of Synthetic and Natural Bacterial (Endotoxic) Virulence Factors: A General Principle
Medicinal Chemistry Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets